Change afib clinicaltrials.gov
WebJan 16, 2024 · Several large multicenter trials of subclinical AF have led to a dramatic change in clinical practice, particularly with regard to anticoagulation. ... (The Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial fibrillation; ClinicalTrials.gov. Unique identifier: NCT01938248) ... WebThe answers provided will help the CHANGE AFib team while working with your site during trial startup. Submission of this survey is not required for trial participation. First Name * Required. Last Name * Required. Email * Required. …
Change afib clinicaltrials.gov
Did you know?
WebIntroduction. The ClinicalTrials.gov Protocol Registration and Results System (PRS) is a web-based tool used to submit clinical study information to ClinicalTrials.gov. Records submitted through the PRS are available to the public at ClinicalTrials.gov. This document describes how to use the PRS and provides step-by-step instructions for PRS ... WebOct 8, 2024 · Over 2000 hospitals and ambulatory clinics partner with the American Heart Association to improve evidence-based care for stroke, acute coronary syndromes, heart failure, or atrial fibrillation, and outpatient patient care outcomes. Investigators are invited to collaborate with the AHA in clinical research by joining GWTG-CORE.
WebEligibility. Age >=21 years. First-detected atrial fibrillation (defined as atrial fibrillation diagnosed in the previous 120 days) Acute care encounter for evaluation or treatment of atrial fibrillation, within 120 days. Electrocardiographic documentation of atrial fibrillation. Estimated life expectancy of at least 1 year. WebJul 30, 2024 · LVEF improved in both groups (LVEF change at 2 years: ERC 5.3±11.6%, usual care 4.9±11.6%, P =0.43). ERC also improved the composite outcome of death or hospitalization for worsening of heart failure. Conclusions: Rhythm control therapy conveys clinical benefit when initiated within 1 year of diagnosing atrial fibrillation in patients with ...
WebPatient Population: Subjects with documented symptomatic persistent or longstanding persistent atrial fibrillation defined as having < 3 years continuous Afib duration in whom a catheter ablation procedure is planned; Study Status: In Follow-up; ClinicalTrials.gov: NCT04468334 Caution: Investigational Device. WebStudy Design: Prospective, non-randomized multi-center clinical trial; Objective: To demonstrate the safety and effectiveness of the Cox Maze IV procedure using the AtriCure Bipolar System for treating permanent atrial fibrillation (Afib) during concomitant on-pump cardiac surgery. Number of Subjects and Sites: 55 subjects at 9 U.S. sites
WebApr 13, 2024 · Change Atrial Fibrillation Effect on Quality-of-life Questionnaire (AFEQT) Score [ Time Frame: Baseline and 3 weeks ] ... ClinicalTrials.gov Identifier: NCT05810896 Other Study ID Numbers: 22-1350b : First Posted: April 13, 2024 Key Record Dates: Last Update Posted: ...
WebApr 6, 2024 · The recently presented Renal Hemodialysis Patients Allocated Apixaban Versus Warfarin in Atrial Fibrillation trial (RENAL-AF; ClinicalTrials.gov identifier NCT02942407) compared the efficacy and safety of apixaban and warfarin for stroke prevention in patients with AF and ESRD, but the study was stopped early owing to lack … dod il5 azureWebOct 26, 2024 · A pragmatic clinical trial—CHANGE AFib—will determine whether early treatment with the antiarrhythmic drug dronedarone improves cardiovascular and long-term outcomes in patients presenting with first-detected atrial fibrillation (AF). The trial represents a collaboration between the American Heart Association (AHA) and the Duke … dod ilp listWebOct 26, 2024 · DALLAS, October 26, 2024 – Until now, scientific research about treatment for the most common type of heart arrythmia, atrial fibrillation (AFib), has primarily … dod ilWebAtrial fibrillation is a common arrhythmia with a prevalence of 1% overall in the US, and incident stroke occurs among those with the condition at 4–5% per year. 3,4 Oral anticoagulation decreases the rate of stroke for patients with atrial fibrillation by more than two-thirds. 5 Although well-established as an effective therapy, during the ... dod iod loginWebIn order to be eligible for CHANGE AFIB, a patient must have had an acute care encounter at the hospital for atrial fibrillation. For eligibility, this is defined as an acute care … dod ilp programWebCHANGE AFib will be conducted within 200 hospitals participating in the American Heart Association’s Get With The Guidelines® - AFib (GWTG-AFib) Program. Data will be submitted through the GWTG-AFib Registry. Not participating in GWTG-AFib and want to join CHANGE AFib? ... ClinicalTrials.gov Identifier: NCT05130268. dod imageryWebOct 21, 2024 · What is CHANGE AFib? October 21, 2024 CHANGE AFib is a pragmatic randomized clinical trial investigating whether the early use of dronedarone can improve outcomes in patients with first-detected atrial fibrillation (AFib). dod iot\\u0026e